Page last updated: 2024-08-23

azides and B-Cell Leukemia

azides has been researched along with B-Cell Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, Y; Du, J; Hampton, EN; Hardy, IR; Kim, CH; Ma, J; Mazagova, M; Nunez, V; Ramadoss, NS; Rodgers, DT; Schulman, A; Schultz, PG; Shen, J; Singer, O; Wang, F; Woods, AK; Wright, TM; Young, TS1
Cao, Y; Choi, SH; Fonslow, BR; Kazane, SA; Kim, CH; Kim, JY; Kim, MS; Kochenderfer, JN; Ma, JS; Pugh, HM; Rodgers, DT; Schultz, PG; Singer, O; Sun, SB; Wright, TM; Young, TS; Yun, HY1

Other Studies

2 other study(ies) available for azides and B-Cell Leukemia

ArticleYear
Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies.
    Proceedings of the National Academy of Sciences of the United States of America, 2016, Jan-26, Volume: 113, Issue:4

    Topics: Animals; Antigens, CD19; Antigens, Neoplasm; Azides; B-Lymphocytes; Basic-Leucine Zipper Transcription Factors; Cell Line, Tumor; Cytokines; Cytotoxicity, Immunologic; Dose-Response Relationship, Immunologic; Female; Genes, Reporter; Genetic Vectors; Humans; Immunotherapy, Adoptive; Leukemia, B-Cell; Lymphocyte Activation; Lymphopenia; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Phenylalanine; Protein Engineering; Receptors, Antigen, T-Cell; Recombinant Fusion Proteins; Saccharomyces cerevisiae Proteins; Sialic Acid Binding Ig-like Lectin 2; Single-Chain Antibodies; Structure-Activity Relationship; T-Cell Antigen Receptor Specificity; T-Lymphocyte Subsets; Xenograft Model Antitumor Assays

2016
Versatile strategy for controlling the specificity and activity of engineered T cells.
    Proceedings of the National Academy of Sciences of the United States of America, 2016, Jan-26, Volume: 113, Issue:4

    Topics: Animals; Antigens, CD19; Antigens, Neoplasm; Azides; B-Lymphocytes; Cell Line, Tumor; Cytotoxicity, Immunologic; Female; Fluorescein-5-isothiocyanate; Genetic Vectors; Humans; Immunotherapy, Adoptive; Lentivirus; Leukemia, B-Cell; Lymphocyte Activation; Lymphopenia; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Models, Molecular; Phenylalanine; Protein Conformation; Protein Engineering; Receptors, Antigen, T-Cell; Recombinant Fusion Proteins; Sialic Acid Binding Ig-like Lectin 2; Single-Chain Antibodies; T-Cell Antigen Receptor Specificity; T-Lymphocytes; Transduction, Genetic; Xenograft Model Antitumor Assays

2016